Labs in Court

Subscribe today for access to
Articles and Reports

By Danielle Sloane, Morgan Tandy | Oct 28, 2024 | 1 min read

Recent enforcement actions involved usual targets such as COVID-19, genetic, and urine drug testing, but EKRA also made an appearance

Recent DOJ settlements continue to focus on issues involving medical necessity and marketer compensation

By Karen Lovitch, Jane Haviland | Jul 24, 2024 | 1 min read

COVID-19-related schemes dominated recent enforcement efforts, which include a national healthcare fraud enforcement action

By Morgan Tandy, Danielle Sloane | Jun 24, 2024 | 1 min read

Genetic testing related fraud was a theme in recent enforcement actions involving medical laboratories and lab testing

Examining DOJ and OIG investigations of labs and their owners: Recent cases show continued focus on the usual enforcement targets.

By Danielle Sloane, Morgan Tandy | Apr 25, 2024 | 1 min read

Recent enforcement actions and court cases include kickback schemes a-plenty and a reminder to focus on HIPAA compliance

By Karen Lovitch, David Gilboa | Mar 25, 2024 | 1 min read

Recent enforcement actions include convictions and guilty pleas for false claims-related allegations involving toxicology labs.

Recent cases show labs should be wary of issues such as improper relationships, medical necessity, kickbacks, and potential telehealth fraud.

By Glenn S. Demby | Jan 2, 2024 | 1 min read

Recent cases involve Medicare’s 14-Day Rule, improper PHI disclosure to a media outlet, kickbacks, and COVID-19 fraud.

By Glenn S. Demby | Nov 24, 2023 | 1 min read

A settlement for kickback allegations, prison time for lab owners convicted of COVID-19 fraud, and 10x Genomics gets OK for lawsuit.

By Glenn S. Demby | Oct 20, 2023 | 1 min read

This month’s roundup of cases includes Walgreens’ settlement with Theranos customers, kickbacks, and age discrimination.

By Glenn S. Demby | Sep 25, 2023 | 1 min read

Recent cases involve charges and judgments related to COVID-19 add-on tests, genetic testing fraud, and kickbacks.

By Glenn S. Demby | Aug 31, 2023 | 1 min read

In last month’s key cases, Illumina and Guardant seek to dismiss lawsuit related to trade secrets and breach of contract.